APA (7th ed.) Citation

He, X., Huang, S., Jiang, Q., Huang, C., Huang, W., & Liang, W. (2025). Efficacy and safety of PD-1/PD-L1 inhibitor monotherapy or combination therapy versus platinum-based chemotherapy as a first-line treatment of advanced urothelial cancer: A systematic review and meta-analysis. Current urology, 19(3), 157-167. https://doi.org/10.1097/CU9.0000000000000275

Chicago Style (17th ed.) Citation

He, Xiaohui, Shibo Huang, Qiuhong Jiang, Conghui Huang, Weisheng Huang, and Weiming Liang. "Efficacy and Safety of PD-1/PD-L1 Inhibitor Monotherapy or Combination Therapy Versus Platinum-based Chemotherapy as a First-line Treatment of Advanced Urothelial Cancer: A Systematic Review and Meta-analysis." Current Urology 19, no. 3 (2025): 157-167. https://doi.org/10.1097/CU9.0000000000000275.

MLA (9th ed.) Citation

He, Xiaohui, et al. "Efficacy and Safety of PD-1/PD-L1 Inhibitor Monotherapy or Combination Therapy Versus Platinum-based Chemotherapy as a First-line Treatment of Advanced Urothelial Cancer: A Systematic Review and Meta-analysis." Current Urology, vol. 19, no. 3, 2025, pp. 157-167, https://doi.org/10.1097/CU9.0000000000000275.